Biotest Aktiengesellschaft

WBAG:BIO3 Stock Report

Market Cap: €1.4b

Biotest Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BIO3?
Owner TypeNumber of SharesOwnership Percentage
Institutions387,3430.979%
Public Companies19,219,85448.6%
General Public19,964,25550.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 49.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
48.6%
Grifols, S.A.
19,219,854€660.2m0%no data
0.31%
Waystone Management Company (IE) Limited
123,139€4.2m0%4.24%
0.24%
Ersel Hedge SGR S.p.A.
93,998€3.2m0%5.77%
0.12%
Knoesel & Ronge Vermögensverwaltung GmbH & Co. Kg
46,000€1.6m0%1.99%
0.11%
VM Vermogens-Management GmbH
42,401€1.5m0%0.44%
0.082%
Ersel Asset Management Sgr S.p.A.
32,344€1.1m-68.4%0.14%
0.062%
FPS Vermoegensverwaltung GmbH
24,614€845.5k0%1.84%
0.032%
Monega Kapitalanlagegesellschaft mbH
12,819€440.3k0%0.06%
0.025%
Arvernus Capital Ltd.
10,028€344.4k0%5.11%
0.005%
Bantleon Bank AG, Asset Management Arm
2,000€68.6k0%0.08%